Literature DB >> 23137156

Neuropsychiatric adverse events and oseltamivir for prophylaxis.

Mark Jones, Rokuro Hama, Tom Jefferson, Peter Doshi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23137156     DOI： 10.1007/bf03262007

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  6 in total

1.  Rethinking credible evidence synthesis.

Authors:  Peter Doshi; Mark Jones; Tom Jefferson
Journal:  BMJ       Date:  2012-01-17

2.  Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.

Authors:  F G Hayden; R L Atmar; M Schilling; C Johnson; D Poretz; D Paar; L Huson; P Ward; R G Mills
Journal:  N Engl J Med       Date:  1999-10-28       Impact factor: 91.245

3.  Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.

Authors:  P H Peters; S Gravenstein; P Norwood; V De Bock; A Van Couter; M Gibbens; T A von Planta; P Ward
Journal:  J Am Geriatr Soc       Date:  2001-08       Impact factor: 5.562

4.  [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].

Authors:  S Kashiwagi; S Kudoh; A Watanabe; I Yoshimura
Journal:  Kansenshogaku Zasshi       Date:  2000-12

Review 5.  Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review.

Authors:  Stephen Toovey; Craig Rayner; Eric Prinssen; Tom Chu; Barbara Donner; Bharat Thakrar; Regina Dutkowski; Gerhard Hoffmann; Alexander Breidenbach; Lothar Lindemann; Ellen Carey; Lauren Boak; Ronald Gieschke; Susan Sacks; Jonathan Solsky; Ian Small; David Reddy
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 6.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.

Authors:  Tom Jefferson; Mark A Jones; Peter Doshi; Chris B Del Mar; Carl J Heneghan; Rokuro Hama; Matthew J Thompson
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18
  6 in total
  4 in total

1.  Effects of alcohol on human carboxylesterase drug metabolism.

Authors:  Robert B Parker; Zhe-Yi Hu; Bernd Meibohm; S Casey Laizure
Journal:  Clin Pharmacokinet       Date:  2015-06       Impact factor: 6.447

2.  Physiologically based pharmacokinetic modeling of impaired carboxylesterase-1 activity: effects on oseltamivir disposition.

Authors:  Zhe-Yi Hu; Andrea N Edginton; S Casey Laizure; Robert B Parker
Journal:  Clin Pharmacokinet       Date:  2014-09       Impact factor: 6.447

Review 3.  Neuraminidase inhibitors for preventing and treating influenza in adults and children.

Authors:  Tom Jefferson; Mark A Jones; Peter Doshi; Chris B Del Mar; Rokuro Hama; Matthew J Thompson; Elizabeth A Spencer; Igho Onakpoya; Kamal R Mahtani; David Nunan; Jeremy Howick; Carl J Heneghan
Journal:  Cochrane Database Syst Rev       Date:  2014-04-10

Review 4.  Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments.

Authors:  Tom Jefferson; Mark Jones; Peter Doshi; Elizabeth A Spencer; Igho Onakpoya; Carl J Heneghan
Journal:  BMJ       Date:  2014-04-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.